Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Effects of Psilocybin in Patients With Amyotrophic Lateral SclerosisClinicalTrials.gov · 2026-08-11An Open-Label Trial Protocol to Test Menstrual Cycle Effects and Tolerance to Low-Dose Psilocybin in Healthy Menstruating Persons.Pharmacology · 2026-08-10Psilocybin induces stereotyped movements and reduces defensive responding in planarians through 5-hydroxytryptamine mechanismsBehavioural Pharmacology · 2026-08-01The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.ClinicalTrials.gov · 2026-05-08PDE4B Inhibition and Psilocybin as Promising Approaches for Treating Methamphetamine Use Disorder: Preclinical Evidence From Rat Models (Abstract ID: 232554)The Journal of Pharmacology and Experimental Therapeutics · 2026-05-01From trials to clinics: investigators' perspectives on translating psychedelic research into clinical care.Translational behavioral medicine · 2026-01-07From fungi to pharmacy: Applied technologies in psilocybin production and its therapeutic applicationsCreative Science · 2025-12-19Acute Kidney Failure and Myocarditis Triggered by Magic Mushroom Toxicity in a Patient With Prior Cocaine Exposure.Cureus · 2025-11-01Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trial.Pilot and feasibility studies · 2025-10-28Real-world use of classic and non-classic psychedelics in Hispanic/Latino adults with Obsessive-Compulsive Disorder: International findings from the LATINO Study.UNC Libraries · 2025-10-09ALSUntangled #77: Psilocybin.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2025-05-01Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing MushroomsPsyArXiv · 2025-02-28Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing MushroomsPsyArXiv · 2025-02-28Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing MushroomsPsyArXiv · 2025-02-28A landscape analysis of psychedelic retreat organizations advertising online.PloS one · 2025-01-01Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing MushroomsPsyArXiv · 2024-11-07Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing MushroomsPsyArXiv · 2024-11-07Psychedelics as a tool for a more connected and sustainable world? Considering the importance of rituals, boundaries, and commitment.The International journal on drug policy · 2024-11-01A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)- and psilocybin-related death in Australia.Addiction (Abingdon, England) · 2024-09-01Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocolWellcome Open Res · 2024-07-24Bridging Psilocybin-Induced Changes in the Brain's Dynamic Functional Connectome With an Individual's Subjective Experience.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2024-07-01Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol.Wellcome open research · 2024-01-01The entropic heart: Tracking the psychedelic state via heart rate dynamicsbioRxiv · 2023-11-09Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin usePsyArXiv · 2023-10-14An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).Pilot and feasibility studies · 2023-10-05Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain's control energy landscape.Nature communications · 2022-10-03Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-17Psychedelics and their therapeutic effectsUniversity of Debrecen Electronic Archive · 2021-11-09Blinding and expectancy confounds in psychedelic randomized controlled trials.Expert review of clinical pharmacology · 2021-09-01Blinding and Expectancy Confounds in Psychedelic Randomised Controlled TrialsPsyArXiv · 2021-03-08Blinding and Expectancy Confounds in Psychedelic Randomised Controlled TrialsPsyArXiv · 2021-03-08Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives.NeuroImage · 2019-10-15Decreased Directed Functional Connectivity in the Psychedelic StatebioRxiv · 2019-07-16Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin.Scientific reports · 2017-04-19Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol useCurrent Opinion in Behavioral Sciences · 2016-11-14Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.Molecular & cellular proteomics: MCP · 2014-05-01Broadband cortical desynchronization underlies the human psychedelic state.The Journal of neuroscience: the official journal of the Society for Neuroscience · 2013-09-18Spirituality and Hallucinogen Use: Results from a Pilot Study among College StudentsInternational Journal of Transpersonal Studies · 2012-06-30Novel, unifying mechanism for mescaline in the central nervous system: electrochemistry, catechol redox metabolite, receptor, cell signaling and structure activity relationships.Oxidative medicine and cellular longevity · 2009-01-01Liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of multiple hallucinogens, chlorpheniramine, ketamine, ritalinic acid, and metabolites, in urine.Journal of analytical toxicology · 2007-10-01